Patent ID: 11932647
Assignee: ABM THERAPEUTICS CORPORATION
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. A compound of Formula (I-5b):, or a pharmaceutically acceptable salt or isotopic derivative thereof, wherein:
Z1 is O, S, NRc or CRdRe;
Z2 is a bond or NRf;
m is 0, 1, 2 or 3;
n is 1, 2 or 3;
R1, R2, R3, Ra, Rd, and Re are each independently selected from the group consisting of hydrogen, halogen, —CN, —NO2, substituted or unsubstituted C1-C6 alkyl, substituted or unsubstituted C2-C6 alkenyl, substituted or unsubstituted C2-C6 alkynyl, —ORg, —SRg, —S(O)2Rg, —NRhRi, —C(O)Rg, —OC(O)Rg, —C(O)ORg, —C(O)NRhRi, —OC(O)NRhRi, —NRgC(O)Rh, —NRgC(O)ORh, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, and substituted or unsubstituted heterocycloalkyl; and
Rc, Rg, Rh, and Ri are each independently H, C1-C6 alkyl, or C1-C6 haloalkyl.